On the Tip of a Needle: A Safer Route to Septal Reduction in HOCM?

Abstract excerpt

Septal reduction therapy remains a cornerstone in the management of drug-refractory obstructive hypertrophic cardiomyopathy (HOCM), with surgical myectomy and alcohol septal ablation (ASA) as established modalities. However, both approaches are limited by procedural morbidity, particularly injury to the cardiac conduction system. This editorial examines a preclinical investigation by Xu et al., which evaluates a n...

Topics

Open a Topic to create a Post that cites this publication.

• Cardiac Surgical Procedures
• Cardiomyopathy and Myosin Studies
• Cardiomyopathy, Hypertrophic
• Cardiovascular Agents
• Genetic Predisposition to Disease
• Genetic Therapy
• Phenotype
• Treatment Outcome

Identifiers and source

Literature Corpus work

c2a80ae7-23c7-5836-bff3-5d8bef271802

DOI

10.22541/au.175332437.77504743/v1